Medicare Enrolled
Dr. Adam Cerel, MD
Cardiovascular Disease · Ayer, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cerel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cerel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cerel
Dr. Adam Cerel is a cardiovascular disease specialist in Ayer, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cerel performed 8,581 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cerel received a total of $15,296 from 43 pharmaceutical and/or device companies across 756 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cerel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in MA
$15,296 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,581
Medicare services
Top 2% in MA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,846 | $72 | $150 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
1,032 | $125 | $477 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
741 | $12 | $60 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
440 | $18 | $60 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
440 | $12 | $50 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
385 | $48 | $98 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
290 | $136 | $389 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
260 | $93 | $200 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
203 | $11 | $52 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
196 | $19 | $48 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
182 | $63 | $154 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
140 | $40 | $120 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
128 | $70 | $150 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
93 | $58 | $117 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $139 | $225 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
37 | $74 | $138 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $61 | $150 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
27 | $16 | $25 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
16 | $153 | $262 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
13 | $92 | $425 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
17.6% high complexity
16.4% medium
66.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,296
Total received (2018-2024)
Avg $2,185/year across 7 years
Top 19% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
756
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,801
2023
$1,975
2022
$2,603
2021
$2,109
2020
$2,039
2019
$2,988
2018
$1,781
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$309
Novartis Pharmaceuticals Corporation
$263
PFIZER INC.
$240
Kiniksa Pharmaceuticals International, plc
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Amgen Inc.
$97
Novo Nordisk Inc
$77
Merck Sharp & Dohme LLC
$73
Janssen Pharmaceuticals, Inc
$64
SCPHARMACEUTICALS INC.
$61
Baxter Healthcare
$56
HEARTFLOW, INC.
$54
GlaxoSmithKline, LLC.
$50
Esperion Therapeutics, Inc.
$45
Janssen Scientific Affairs, LLC
$31
Bayer Healthcare Pharmaceuticals Inc.
$29
AltaThera Pharmaceuticals LLC
$26
Vital Connect, Inc
$22
Lexicon Pharmaceuticals, Inc.
$21
Boston Scientific Corporation
$17
INOGEN, INC.
$4
Top 3 companies account for 45.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$2,383
PFIZER INC.
$1,839
Novartis Pharmaceuticals Corporation
$1,646
SANOFI-AVENTIS U.S. LLC
$1,445
Amgen Inc.
$1,426
AstraZeneca Pharmaceuticals LP
$1,313
Boehringer Ingelheim Pharmaceuticals, Inc.
$585
GlaxoSmithKline, LLC.
$537
Amarin Pharma Inc.
$486
Merck Sharp & Dohme LLC
$445
E.R. Squibb & Sons, L.L.C.
$434
Regeneron Healthcare Solutions, Inc.
$433
Novo Nordisk Inc
$268
Bardy Diagnostics, Inc.
$207
Kiniksa Pharmaceuticals, Ltd.
$205
Kowa Pharmaceuticals America, Inc.
$171
Kiniksa Pharmaceuticals International, plc
$164
Boston Scientific Corporation
$149
Esperion Therapeutics, Inc.
$140
BOSTON SCIENTIFIC CORPORATION
$95
Bayer Healthcare Pharmaceuticals Inc.
$87
Gilead Sciences, Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$80
Merck Sharp & Dohme Corporation
$73
Baxter Healthcare
$70
SCPHARMACEUTICALS INC.
$61
HEARTFLOW, INC.
$54
InfoBionic, Inc
$43
AltaThera Pharmaceuticals LLC
$39
Eisai Inc.
$39
Allergan Inc.
$38
Abbott Laboratories
$32
Janssen Scientific Affairs, LLC
$31
Smith & Nephew, Inc.
$25
Medtronic, Inc.
$25
RGH Enterprises LLC
$24
Exact Sciences Corporation
$22
Vital Connect, Inc
$22
Lexicon Pharmaceuticals, Inc.
$21
Lilly USA, LLC
$21
Braemar Manufacturing, LLC
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$12
INOGEN, INC.
$4
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
ANORO ELLIPTA · Adempas · Amitiza · Arcalyst · BREO · BREZTRI · BRILINTA · BYSTOLIC · CHANTIX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Cologuard Collection Kit · Corlanor · Dayvigo · Dexilant · ELIQUIS · ENTRESTO · FARXIGA · FFRct · FUROSCIX · HeartMate · Hillrom - Carnation Ambulatory Monitor · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INVOKANA · JARDIANCE · Kerendia · LEQVIO · LUX-Dx Insertable Cardiac Monitor · Launcher · LifeVest · Livalo · MOUNJARO · MULTAQ · MoMe Kardia · NEXLETOL · NO PRODUCT DISCUSSED · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Repatha · SPIRIVA RESPIMAT · SYMBICORT · Santyl · Sotalol Hydrochloride · TRELEGY ELLIPTA · Trintellix · VERQUVO · VITALPATCH RTM · VRAYLAR · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
114
County median income
$126,779
Nearest hospital to ZIP centroid (approximate)
NASHOBA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cerel is a clinical cardiology specialist, with above-average Medicare volume (top 2% in MA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cerel experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Cerel performed 3,846 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cerel receive payments from pharmaceutical companies?
Yes. Dr. Cerel received a total of $15,296 from 43 companies across 756 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cerel's costs compare to other cardiologists in Ayer?
Dr. Cerel's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cerel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Ayer
Browse cardiologists in Ayer ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology